##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||||Restricted|Unrestricted|Total|Total|
|---|---|---|---|---|---|---|---|
|||||funds|funds|2023|2022|
||||Notes|8||6|6|
|INCOME||||||||
|Charitable
income||||||||
|Membership
subscriptions|||||209,236|209,236|198,396|
|Study days|||||212,060|212,060|152,805|
|e-ELCA||||4,500||4,500|4,000|
|FAMCARE subscriptions|||||7,125|7,125|8,493|
|Website advertisements|||||3,690|3,690|2,600|
|Other contributions||||3,012||3,012||
|Investment
income|||||2,406|2,406|418|
|TOTAL INCOME||||7,512|434,517|442,929|366,712|
|EXPEND ITURE||||||||
|Charitable
activities||||10,616|421,656|432,272|392,482|
|TOTAL EXPENDITURE||||10,616|421,656|432,272|392,482|
|Net (expenditure)/income|for the year before transfers|||(3,104)|12,861|9,757|(25,770)|
|Transfers
between
funds||||(500)|500|||
|NET (EXPENDITURE)/INCOME||FOR THE YEAR||(3,604)|13,361|9,757|(25,770)|
|Fund balances at 1 December 2022||||147,864|544,006|691,870|717,640|
|FUND BALANCES AT 30 NOVEMBER 2023|||10,11|144,260|557,367|701,627|691,870|
##
||Restricted|Unrestricted|Total|
|---|---|---|---|
||funds|funds|2022|
|Notes|6|6|8|
|INCOME||||
|Charitable
income||||
|Membership
subscriptions||198,396|198,396|
|Study days||152,805|152,805|
|e-ELCA|4,000||4,000|
|FAMCARE subscriptions||8,493|8,493|
|Website advertisements||2,600|2,600|
|Investment
income||418|418|
|TOTAL INCOME|4,000|362,712|366,712|
|EXPENDITURE||||
|Charitable
activities|24,447|368,035|392,482|
|TOTAL EXPENDITURE|24,447|368,035|392,482|
|NET EXPENDITURE FOR THE YEAR BEFORETRANSFERS|(20,447)|(5,323)|(25,770)|
|Transfer between
funds|(2,500)|2,500||
|NET EXPENDITURE FOR THE YEAR|(22,947)|(2,823)|(25,770)|
|Fund balances at 1 December 2021|170,811|546,829|717,640|
|FUND BALANCES AT 30 NOVEMBER 2022|147,864|544,006|691,870|
##
##
||||||2023||2022|
|---|---|---|---|---|---|---|---|
||||Notes|||||
|FIXEDASSETS||||||||
|Tangible assets||||||||
|Investments|||||85,000|||
|CURRENT ASSETS||||||||
|Debtors||||75,223||102,242||
|Cash at bank and||in hand||561,604||630,928||
|||||636,827||733,170||
|CREDITORS: amounts||falling||||||
|due within one year||||(20,200)||(41,300)||
|NET CURRENT ASSETS|||||616,627||691,870|
|NET ASSETS|||10||701,627||691,870|
|FUNDS||||||||
|Restricted funds|||10||144,260||147,864|
|Designated
funds|||11||194,912||187,066|
|Other unrestricted|funds||11||362,455||356,940|
|TOTAL FUNDS|||||701,627||691,870|
##
##
##
##
##
##
##
##
##
##
##
##
|||||||Surplus I|
|---|---|---|---|---|---|---|
|STUDY DAYS AND EVENTS||||Income
f|Expenditure
f:|(deficit)
f.|
|PCC 2023||||188,650|(192,727)|(4,077)|
|Ethics Course - September|2022|||756|(2,784)|(2,028)|
|SAS & Hospice Doctors Study Series 23 Nov &8 Dec 2022||||286|(1,500)|(1,214)|
|Trainees Committee
Study|Day - Research|Why Bother||903|(1,060)|(157)|
|APM &PCRS Research Course 2023||||4,879|(3,651)|1,227|
|CESRWorkshop
Webinar,|May 2023|||233|(500)|(267)|
|ARCP Preparation
Webinar,|May 2023|||976|(500)|476|
|Ethics Course, September 2023||||3,886|(2,420)|1,466|
|HDMU Study Series, September 2023||||10,734|(2,084)|8,650|
|Juniors Conference
- 18Nov 2023||||756||756|
|||||212,060|(207,226)|4,834|
||||Restricted|Unrestricted|Total|Total|
|CHARITABLE ACTIVITIES|EXPENDITURE||funds
K|funds
K|2023
E|2022f|
|Direct Charitable
Expenditure|||||||
|Study days (see note 3)||||207,226|207,226|167,215|
|e-ELCA|||9,500||9,500|24,438|
|British Medical Journal Subscriptions||||20,000|20,000|21,440|
|Sage Publications
(Palliative|Medicine Journal)|||12,700|12,700|12,360|
|Pharmaceutical
Press||||53,715|53,715|53,715|
|Research and prize giving||||350|350||
|Advertising||||||1,875|
|Support Costs|||||||
|Contribution
for President
and Vice|||||||
|President's
costs (see|note 5)|||45,040|45,040|28,867|
|Secretariat|||1,116|64,859|65,975|70,009|
|Travel and accommodation||||1,402|1,402|337|
|Office expenditure
and
IT support||||6,713|6,713|7,109|
|Stationery,
photocopying
and printing||||362|362|282|
|Postage||||1,371|1,371|1,380|
|Insurance||||754|754|554|
|Bank charges||||164|164|126|
|Legal and professional
fees||||4,156|4,156||
|Accountancy
and independent
examination||||2,844|2,844|2,775|
||||10,616|421,656|432,272|392,482|
##
##
|TRUSTEE COSTS||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|During the year, the|following||||disbursements||||were|made:||||||
|||||||||||||||2023|2022|
|Recipient||||||||||Reason|||||f|
|Great Western
Hospitals|||NHS|||||||Dr Natasha||Wiggins time as Treasurer||15,459||
|Chelsea and Westminster||||Hospital||||||Dr Sarah|Cox time as President|||19,648|17,204|
|The Leeds Teaching|Hospitals||||NHS|||||Dr Suzanne||Kite time as Vice-President||7,549||
|Lancashire
Teaching||Hospitals||||NHS||||Dr Kirsten|Baron time as Hon||Secretary|1,874|1,874|
|Wrighton
&Leigh NHS||||||||||Dr Kirsten|Baron time as Hon||Secretary||3,122|
|Severn hospice Ltd||||||||||Prof Derek||Willis time as Treasurer|||6,667|
|Three trustees (2022:||Nil)||||||||Outgoing|trustees
recognition||ofservice|510||
|Three trustees (2022:||2)||||||||Travel and||subsistence costs|reimbursed|983|216|
|No director received|emoluments||||||during|the current year nor||||the prior year.||||
|TANGIBLE FIXEDASSETS||||||||||||||||
|||||||||||||||Website|Total|
|||||||||||||||L|X.|
|COST||||||||||||||||
|At beginning
and end||of|year|||||||||||3,072|3,072|
|DEPRECIATION||||||||||||||||
|At beginning
and end||of|year|||||||||||3,072|3,072|
|NET BOOK VALUE||||||||||||||||
|At end ofyear||||||||||||||||
|At beginning
ofyear||||||||||||||||
|FIXEDASSET INVEST MENTS||||||||||||||||
|685,000 has been invested||||in|a|3|year ethical||bond.|||||||
|DEBTORS||||||||||||||2023|2022|
|||||||||||||||6|6|
|Other trade debtors||||||||||||||1,200|4,445|
|Prepayments
(including|||PCC 2024)|||||||||||66,247|90,021|
|Website under construction||||||||||||||7,776|7,776|
|||||||||||||||75,223|102,242|
|CREDITORS: amounts||falling|||due||within|one|year|||||2023|2022|
|||||||||||||||6|6|
|Secretariat costs|||||||||||||||6,872|
|Other accruals||||||||||||||5,493|2,239|
|Deferred income (including||||PCC||2024)||||||||8,879|24,884|
|Other creditors||||||||||||||5,828|7,305|
|||||||||||||||20,200|41,300|
##
##
|RESTRICTED FUNDS|Balance at||||Balance at 30|
|---|---|---|---|---|---|
||1 December 2022|Income|Expenditure|Transfers|November
2023|
||E|E|E|||
|BRCT|13,926||||13,926|
|e-ELCA|133,938|4,500|(10,616)|(500)|127,322|
|Juniors Committee||3,012|||3,012|
||147,864|7,512|(10,616)|(500)|144,260|
||Balance at||||Balance at 30|
||1 December 2021|Income|Expenditure|Transfers|November
2022|
|||E|E|||
|BRCT|13,935||(9)|-|13,926|
|e-ELCA|156,876|4,000|(24,438)|(2,500)|133,938|
||170,811|4,000|(24,447)|(2,500)|147,864|
##
##
##
##
##
|UNRESTRICTED|UNRESTRICTED|FUNDS|Balance at||||Balance at 30|
|---|---|---|---|---|---|---|---|
||||1 December 2022|Income|Expenditure|Transfers|November
2023|
||||K|E||||
|Education|fund||187,066|212,060|(207,226)||191,900|
|Other unrestricted||funds|356,940|219,445|(214,430)|500|362,455|
||||544,006|431,505|(421,656)|500|554,355|
||||Balance at||||Balance at 30|
||||1 December 2021|Income|Expenditure|Transfers|November
2022|
||||K|f|E||E|
|Education|fund||201,476|152,805|(167,215)||187,066|
|Other unrestricted||funds|345,353|209,907|(200,820)|2,500|356,940|
||||546,829|362,712|(368,035)|2,500|544,006|
##
##
|12|ANALYSIS OF NET ASSETS BETWEEN FUNDS|ANALYSIS OF NET ASSETS BETWEEN FUNDS|Restricted|Unrestricted|TOTAL|
|---|---|---|---|---|---|
||||funds|funds|2023|
||Forthe|year ended 30November 2023|f|6|6|
||Fixed assets|||85,000|85,000|
||Current|assets|144,260|492,567|636,827|
||Current|liabilities||(20,200)|(20,200)|
||||144,260|557,367|701,627|
||||Restricted|Unrestricted|TOTAL|
||||funds|funds|2022|
||Forthe|year ended 30November 2022|6||K|
||Fixed assets|||||
||Current|assets|147,864|585,306|733,170|
||Current|liabilities||(41,300)|(41,300)|
||||147,864|544,006|691,870|